Latest Cancer Research Stories
VABC, the organization dedicated to brain cancer research and advocacy, responds to an article published in Forbes on a Danish study that found no correlation between cell phone use and brain cancer. New York, NY (PRWEB) March 27, 2013 On March 27, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, reacts to a recent Danish study’s findings which indicate that there’s no link between cell phone use and brain cancer. According to...
-- Genomic, Molecular Findings by CHOP Researchers Will Help Inform Personalized Medicine -- PHILADELPHIA, March 26, 2013 /PRNewswire-USNewswire/ -- Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists will be using the ongoing flood of gene-sequencing data to customize treatments based on very specific...
SEATTLE, March 25, 2013 /PRNewswire/ -- The Fred Hutchinson Cancer Research Center Survivorship Program and its directors, K. Scott Baker, M.D. and Karen Syrjala, Ph.D., have been selected to lead a nationwide study that aims to improve long-term health outcomes for cancer survivors between the ages of 18 and 39. Under way this spring, the study will involve the Livestrong Survivorship Center of Excellence Network, a collaborative research group of seven National Cancer...
Hematology / oncology industry expert to lead promising development pipeline BOULDER, Colo., March 21, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointment of Michael N. Needle, M.D., to the position of Chief Medical Officer. Dr. Needle, a board certified hematologist / oncologist, will...
St. Jude Children's Research Hospital plays key role in research showing that drug shortages erode the quality and increase the cost of cancer care; experts warn that shortages persist despite efforts to fix the problem MEMPHIS, Tenn., March 21, 2013 /PRNewswire-USNewswire/ -- A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more...
BOSTON and GREENWOOD, S.C., March 19, 2013 /PRNewswire/ -- Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for its BENCHlab NGS and CNV solutions with South Carolina-based Greenwood Genetic Center, a non-profit institute that provides clinical genetic services and diagnostic laboratory...
One of Just 24 Witnesses at Federal Appropriations Hearing WASHINGTON, March 13, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) calls for Congressional budget action to sustain the nation's biomedical research enterprise at the National Institutes of Health (NIH). Speaking on behalf of the lupus community throughout the country, the LRI testified before the Fiscal 2014 Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies Public...
A team of Canadian and international cancer researchers led by Dr. Brenda Gallie at the Princess Margaret Cancer Centre, University Health Network (UHN), has discovered a new type of retinoblastoma, a rapidly developing eye cancer that affects very young babies– a finding that can immediately change clinical practice and optimize care for these children. The finding, published online today in Lancet Oncology, is a breakthrough in recognizing that a single cancer gene (an oncogene) drives...
A new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "Renal cell carcinoma, a malignant tumor arising from the kidney, is one of the most difficult forms of cancer to detect and treat properly because it remains silent until disseminating to other...
Memorial Sloan-Kettering Cancer Center's national fundraising event has raised more than $31 million for rare cancer research since 2007 with founding partner, Equinox NEW YORK, March 11, 2013 /PRNewswire/ -- More than 12,000 cyclers gathered in ten cities across the country in February and early March to raise more than $13.8 million to support rare cancer research at Memorial Sloan-Kettering Cancer Center. The events took place at Equinox clubs in New York City; Los Angeles; San...
